Premature mortality in people living with a severe mental illness (SMI) is often attributed to
multiple factors including the use of medicines such as antipsychotics. Second-generation …

A significant heterogeneity prevails in antipsychotics (APs) safety monitoring
recommendations. Youths are deemed more vulnerable to cardiometabolic side effects. We …

Objective: This study examined time trends and patient characteristics related to guideline-
recommended cardiometabolic risk factor monitoring among youths treated with …

Background Antipsychotics and mood stabilisers are gathering attention for the disturbance
of metabolism. This network meta-analysis aims to evaluate and rank the metabolic effects of …

Background There is limited evidence on the efficacy of electroconvulsive therapy (ECT) in
adolescents with mental illness. The present study reported outcomes of adolescents with …

Introduction Given the increasing rates of antipsychotic use in multiple psychiatric
conditions, greater attention to the assessment, monitoring and documentation of their side …

Background/Objectives: Risperidone-related metabolic side effects in children have been
primarily linked to variations between guideline-recommended and clinical treatment …

Introduction: Second-generation antipsychotics have seen a significant surge in use for a
variety of pediatric psychiatric problems over the last decade, typically as off-label …

Background: Obstructive sleep apnea (OSA) affects approximately 1 billion people globally
and is highly prevalent in psychiatric patient populations. Comorbid OSA can worsen …

Results: In many cases, the increase in therapeutic doses and treatment duration is
accompanied by the occurrence of severe side effects. Taking into account the huge …